Herbs (Global Traditional) · Traditional Chinese Medicine
Yomogi (Artemisia princeps) (Artemisia princeps)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Yomogi (Artemisia princeps) is a medicinal herb used in traditional Japanese Kampo medicine containing bioactive compounds like artemisinin and flavonoids. Its ethanol extract demonstrates anti-obesity and anti-diabetic effects through modulation of glucose metabolism and lipid accumulation pathways.
Yomogi (Artemisia princeps) is a perennial herb native to East Asia, particularly Japan, Korea, and China, belonging to the Asteraceae family. The leaves are harvested and processed through steam distillation under reduced pressure, dichloromethane extraction, or ethanol extraction to obtain therapeutic extracts. The plant comprises primarily volatile monoterpenoids, sesquiterpenoids, hydrocarbons, and aromatic compounds identified through GC-MS analysis.
No human clinical trials, randomized controlled trials, or meta-analyses for Artemisia princeps were identified in the available research. Current evidence is limited to preclinical studies in mice showing anti-obesity and anti-diabetic effects, and in vitro studies demonstrating various biological activities of essential oils.
No clinically studied dosage ranges are available for Artemisia princeps extracts, powders, or standardized forms due to the absence of human clinical trials. Consult a healthcare provider before starting any new supplement.
Per 100 g of fresh Yomogi (Artemisia princeps) leaves: Water ~80–85 g; Energy ~45–55 kcal; Protein ~5.2 g; Total fat ~0.8 g; Carbohydrates ~8–10 g (including dietary fiber ~6.9 g, among the highest for leafy greens); Ash ~1.5–2.0 g. Vitamins: β-carotene (provitamin A) ~5,300 µg (high; bioconversion to retinol ~1/12 by weight); Vitamin K ~340 µg (notably high, relevant for coagulation); Vitamin C ~35 mg; Vitamin E (α-tocopherol) ~3.2 mg; Folate (B9) ~190 µg; Vitamin B2 (riboflavin) ~0.34 mg; Vitamin B1 (thiamine) ~0.10 mg; Niacin ~2.4 mg. Minerals: Potassium ~890 mg; Calcium ~180 mg; Magnesium ~29 mg; Phosphorus ~100 mg; Iron ~4.3 mg (non-heme; bioavailability enhanced by co-consumed vitamin C); Zinc ~0.6 mg; Manganese ~1.2 mg. Bioactive compounds (key phytochemicals): Essential oil (0.2–0.5% of dry weight) composed primarily of 1,8-cineole (eucalyptol, ~20–35% of oil), α-thujone (~10–25%), β-thujone (~5–15%), camphor (~5–12%), borneol (~3–8%), and β-caryophyllene (~3–7%). Flavonoids: eupatilin (~0.01–0.05% dry weight, a 6-methoxylated flavone with notable gastroprotective and anti-inflammatory activity), jaceosidin (~0.005–0.03% dry weight, a 6-methoxyflavone), luteolin and apigenin glycosides (minor). Caffeoylquinic acids: chlorogenic acid (5-O-caffeoylquinic acid, ~0.5–1.5% dry weight), 3,5-di-O-caffeoylquinic acid (~0.3–0.8% dry weight), and related isomers contributing significant antioxidant capacity; these phenolic acids have moderate oral bioavailability (~30% absorption, extensively metabolized by gut microbiota). Sesquiterpene lactones: artabsin, absinthin (trace to minor amounts, bitter principles). Coumarins: scopoletin, esculetin (trace). Polysaccharides in dried herb contribute prebiotic-type soluble fiber. Chlorophyll content is high (~1.0–1.5 mg/g fresh weight), responsible for the characteristic deep green color used in mochi and other culinary preparations. Bioavailability notes: Fat-soluble vitamins (A, E, K) and terpene-based essential oil constituents are better absorbed with dietary fat; eupatilin and jaceosidin show moderate oral bioavailability in pharmacokinetic studies (~15–30% in rodent models) but undergo extensive first-pass glucuronidation; caffeoylquinic acids are partially hydrolyzed to caffeic acid in the gut, which is then absorbed and conjugated. Thujone content warrants caution with concentrated essential oil use due to neurotoxic potential at high doses (EFSA threshold: 0.5 mg/kg body weight/day).
Yomogi's ethanol extract modulates glucose homeostasis by enhancing insulin sensitivity and inhibiting adipogenesis through PPAR-gamma pathway regulation. Essential oil constituents including camphor and 1,8-cineole demonstrate antimicrobial activity by disrupting bacterial cell membranes. The flavonoid compounds contribute to anti-inflammatory effects through cyclooxygenase and lipoxygenase enzyme inhibition.
Current evidence for yomogi is limited to preclinical studies, with most research conducted in animal models and laboratory settings. Anti-obesity and anti-diabetic effects were demonstrated in high-fat diet-fed mice using ethanol extracts, showing significant reductions in body weight and improved glucose tolerance. Antimicrobial properties have been validated through in vitro studies testing essential oil constituents against various bacterial strains. Human clinical trials investigating yomogi's therapeutic potential are lacking, limiting the strength of evidence for clinical applications.
Yomogi is generally considered safe when used in traditional preparations, but comprehensive safety data is limited. As a member of the Artemisia family, it may cause allergic reactions in individuals sensitive to plants in the Asteraceae family. Potential interactions with anticoagulant medications may occur due to compounds that could affect blood clotting. Pregnant and breastfeeding women should avoid yomogi supplements due to insufficient safety data and potential uterine stimulant effects.
